Need Help? Call 1­-866-­796-­7386
« back to stock screener

  RTRX stock: Retrophin Inc

Current Rating
Sell

Previous Rating

Sell
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$24.78
Market Cap
835.3M
Sector
Health Care
Div. Growth
-
P/E
-
P/B
2.67
P/S
5.43
Dividend %
-
P/CF
10.9
P/FCF
-
Op. Cash Flow
1.5K
FCF
0.0
Op. Margin
-37.90%
Net Margin
-33.80%
ROE
-16.80%
ROI
-13.80%
ROA
-9.80%
EPS Growth
-16.70%
Current Ratio
4.0
Debt/Equity
14.40%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Teva Pharmaceutical Industries (TEVA) $20.71 - 4.50% 19.15B Strong Buy
Champions Oncology Inc (CSBR) $4.06 - - 43.7M Strong Buy
DURECT Corporation (DRRX) $1.17 - - 139.7M Strong Buy
InfuSystem Holdings Inc (INFU) $2.35 - - 52.9M Strong Buy
China Pharma Holdings, Inc. (CPHI) $0.41 - - 7.7M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More